It stimulates insulin secretion, inhibits glucagon production , slows gastric emptying, and promotes satiety
While Ozempic and other GLP-1 agonists primarily target blood sugar regulation, weight loss is a common side effect, with many users experiencing reductions in body fat over time
Additionally, semaglutide GLP-1 has been shown to slow down gastric emptying, leading to increased feelings of fullness and potentially altering nutrient absorption and digestion
For ideas on how to reduce the carb content of some of your favourite foods, the article How to reduce carbs in your diet has many great ideas that wont leave you missing out on flavour
The litigation includes more than 1,500 lawsuits consolidated in Pennsylvania under Judge Karen Marston